Joint BioEnergy Institute
JBEI is a U.S. Department of Energy Bioenergy Research Center led by Lawrence Berkeley National Laboratory, developing advanced biofuels and bioproducts from lignocellulosic biomass via synthetic biology, ionic liquid pretreatment, and AI-enabled laboratory automation for industry licensing and commercialization.
- Company typePrivate
- Founded2007
- HeadquartersEmeryville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Joint BioEnergy Institute does
Joint BioEnergy Institute (JBEI) is a U.S. Department of Energy Bioenergy Research Center established in 2007 and led by Lawrence Berkeley National Laboratory. Headquartered in Emeryville, California, JBEI operates as a federally funded, non-profit research institute with approximately 200 scientists, engineers, and support staff organized across four scientific divisions — Feedstocks, Deconstruction, Biofuels and Bioproducts, and Technology — plus a fifth technology division focused on computational tools. The institute develops integrated technologies for converting lignocellulosic biomass into advanced biofuels and renewable bioproducts, anchored by proprietary ionic liquid pretreatment, synthetic biology and metabolic engineering (using hosts such as Pseudomonas putida, Rhodosporidium toruloides, and Corynebacterium glutamicum), machine learning, genome-scale metabolic modeling, and high-throughput laboratory automation. JBEI's research is delivered to market through a multi-institutional consortium of five national laboratories (Berkeley Lab, Brookhaven, Pacific Northwest, Lawrence Livermore, and Sandia) and seven academic institutions (UC Berkeley, UC Davis, UC San Diego, UC Santa Barbara, Georgia Tech, Northwestern, and University of Adelaide).
JBEI's core IP estate comprises 455 patent applications, 153 issued patents, and 231 executed IP licenses, with 1,320 peer-reviewed publications and 123,000 citations reflecting sustained scientific productivity. Demonstrated technical milestones include distillable amine-based solvent pretreatment achieving over 99% solvent recovery with butylamine, and a combined AI-and-automation pipeline that delivered a five-fold increase in isoprenol production (a jet fuel precursor) while compressing strain development timelines from years to months. The institute's business model is built on three revenue streams: DOE BRC grant funding (approximately $25 million annually under the 2017 $125 million five-year award), technology licensing to industry partners, and sponsored research agreements. Sixteen startups have been formed based on JBEI technology, and the institute maintains public tools including technoeconomic models, retrobiosynthesis web interfaces, and the JBEI Data and KBase platforms. Customers are primarily the DOE and partner research institutions, with industry partners engaged through licensing and sponsored research for commercialization of bioenergy inventions.
Joint BioEnergy Institute firmographics
Firmographics- Name
- Joint BioEnergy Institute
- Legal name
- Joint BioEnergy Institute
- Website
- https://jbei.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- JBEI is a U.S. Department of Energy Bioenergy Research Center led by Lawrence Berkeley National Laboratory, developing advanced biofuels and bioproducts from lignocellulosic biomass via synthetic biology, ionic liquid pretreatment, and AI-enabled laboratory automation for industry licensing and commercialization.
- Ownership category
- akta.pro rank
Joint BioEnergy Institute industry classification
Industry- Product category
- Bioenergy Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates) (IMAMALAA)
- akta.pro secondary industries
- Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA), Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB), Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up) (IMAMALAL), Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM), Bioenergy & Industrial Biomass Crop Farming (Energy Cane, Miscanthus, Switchgrass) (AFAGAGAI)
Keywords
Where Joint BioEnergy Institute is headquartered
LocationHeadquarters
- HQ city
- Emeryville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Joint BioEnergy Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Revenue model
- U.S. Department of Energy Funding: JBEI receives federal funding through DOE's Office of Science as one of four DOE Bioenergy Research Centers. Awarded $125 million over five years (selected July 2017). Previous funding included $25 million annually through 2017 from a five-year renewal.
- Technology Licensing and IP: JBEI generates revenue through licensing intellectual property to industry partners. The institute has 231 IP licensed, 153 issued patents, and 455 patent applications.
- Sponsored Research: Industry partnerships through sponsored research programs where companies fund specific research projects in exchange for access to resulting intellectual property.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Joint BioEnergy Institute product offering
Product offeringCore offering
JBEI conducts federally funded research to develop advanced biofuels and bioproducts from non-food lignocellulosic biomass, organized across four scientific divisions (Feedstocks, Deconstruction, Biofuels and Bioproducts, and Technology). Its deliverables include licensable intellectual property such as ionic liquid pretreatment processes, engineered microbial strains, and AI-driven strain engineering methods, which it transfers to industry through licensing and sponsored research agreements.
Product overview
Joint BioEnergy Institute (JBEI) is a U.S. Department of Energy Bioenergy Research Center led by Lawrence Berkeley National Laboratory, dedicated to developing advanced biofuels and bioproducts from lignocellulosic biomass. Rather than commercial software products, JBEI's offerings consist of scientific research, licensed technologies, and expertise across four research divisions: Feedstocks (bioenergy crop development), Deconstruction (biomass pretreatment and separation technologies), Biofuels and Bioproducts (microbial conversion of sugars to fuels), and Technology (high-throughput laboratory automation and computational tools). JBEI's intellectual property portfolio includes 231 IP licenses, 455 patent applications, and 153 issued patents available for industry licensing.
Differentiator
Problem solved
Functional benefit
Products and services
- Ionic Liquid Pretreatment Technology An affordable, scalable ionic liquid pretreatment process for deconstructing lignocellulosic biomass into fermentable sugars, offered for licensing to industry partners seeking to commercialize advanced biofuel and bioproduct production.
- Sponsored Research Partnerships Contract research programs through which industry partners fund specific bioenergy or bioproducts research at JBEI and receive early access to the resulting intellectual property and collaborative development opportunities.
- Engineered Microbial Conversion Platforms Licensable engineered microorganisms and metabolic pathways that convert biomass-derived sugars into drop-in blendstocks for gasoline, diesel, and jet fuels, available through JBEI's Inventions for Licensing program.
- Engineered Bioenergy Crops Patented genetic improvements to bioenergy crops that increase sugar-containing polymers and decrease lignin in plant cell walls, enabling more efficient downstream deconstruction and offered for licensing.
- Distillable Amine-Based Pretreatment Solvents Licensable distillable amine-based solvents (notably butylamine) for biorefinery pretreatment, validated across 22 biomass feedstocks with over 99% solvent recovery and high sugar yields.
- Open-Source Bioenergy Research Tools Freely accessible research tools and datasets — including technoeconomic models, retrobiosynthesis web interfaces, the JBEI Data platform, and KBase integration — provided to academic and industry users for systems biology and bioenergy research.
Quantifiable outcome
- Over 99% solvent recovery rates using butylamine for biorefinery pretreatment across diverse feedstocks
- +3 more outcomes
Companies that use Joint BioEnergy Institute
Customer profileSegments4 records
Ideal customer profiles3 records
Joint BioEnergy Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Joint BioEnergy Institute partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core.
- Lawrence Berkeley National Laboratory (Berkeley Lab)coreBerkeley Lab serves as the lead institution for JBEI. Selected in July 2017 as one of four DOE Bioenergy Research Centers with $125 million in funding. Berkeley Lab provides the primary research facilities in Emeryville and overall organizational leadership.
- Brookhaven National LaboratorycoreOne of five national laboratory partners in the JBEI research consortium, contributing scientific expertise and resources to bioenergy research programs.
- Pacific Northwest National LaboratorycoreOne of five national laboratory partners in the JBEI research consortium, contributing scientific expertise and resources to bioenergy research programs.
- Lawrence Livermore National LaboratorycoreOne of five national laboratory partners in the JBEI research consortium, contributing scientific expertise and resources to bioenergy research programs.
- Sandia National LaboratoriescoreOne of five national laboratory partners in the JBEI research consortium, contributing scientific expertise and resources to bioenergy research programs.
- Georgia Institute of TechnologycoreOne of seven academic research partners in the JBEI consortium, providing research collaboration in bioenergy and bioproducts development.
- Northwestern UniversitycoreOne of seven academic research partners in the JBEI consortium, providing research collaboration in bioenergy and bioproducts development.
- University of AdelaidecoreOne of seven academic research partners in the JBEI consortium (international partner), providing research collaboration in bioenergy and bioproducts development.
- UC BerkeleycoreOne of seven academic research partners and the primary university connection through Berkeley Lab leadership. Contributing research collaboration in bioenergy and bioproducts development.
- UC DaviscoreOne of seven academic research partners in the JBEI consortium, conducting field trials of engineered and wild type energy crops at UC Davis facilities.
- UC San DiegocoreOne of seven academic research partners in the JBEI consortium, providing research collaboration in bioenergy and bioproducts development.
- UC Santa BarbaracoreOne of seven academic research partners in the JBEI consortium, providing research collaboration in bioenergy and bioproducts development.
- DOE Bioenergy Research Centers (BRCs)coreJBEI is one of four DOE Bioenergy Research Centers. The other three include Center for Bioenergy Innovation (CBI) led by Oak Ridge, Great Lakes Bioenergy Research Center (GLBRC) led by UW-Madison, and Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) led by UIUC. These centers collaborate on breakthrough science in carbon-neutral biofuels and bioproducts development.
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
Joint BioEnergy Institute competitors and assessment
Company assessmentDirect peers
- Codexis: A protein engineering company developing engineered enzymes and biocatalysts for pharmaceutical, food, and industrial applications including biorefining. Directly comparable to JBEI's enzyme and microbial engineering capabilities, but operating as a publicly traded commercial company with a focused commercial customer base.
- ICM Inc. A U.S. biorefinery process technology provider and equipment manufacturer that designs and licenses commercial-scale ethanol and cellulosic biofuel plants. Directly comparable to JBEI's biorefinery technology and pretreatment work, but operating as a private industrial technology licensor serving commercial biorefinery operators.
- Gevo: A renewable fuels company developing low-carbon-intensity hydrocarbons including sustainable aviation fuel (SAF) and renewable gasoline from biomass-derived feedstocks. Directly comparable to JBEI's lignocellulosic-to-jet/diesel platform work, but operating at commercial scale with public-market financing.
- Center for Bioenergy Innovation (CBI): A DOE Bioenergy Research Center led by Oak Ridge National Laboratory and one of the other three sister BRCs to JBEI. Directly comparable in mission, scope, and federal funding mechanism, focused on converting biomass to bioenergy and bioproducts via synthetic biology and process engineering.
- Great Lakes Bioenergy Research Center (GLBRC): One of the other three DOE Bioenergy Research Centers (alongside JBEI), led by the University of Wisconsin–Madison and Michigan State University. Directly comparable as a federally funded multi-institutional research consortium pursuing lignocellulosic biofuels and bioproducts with similar funding structure, mission, and peer-reviewed output model.
- Amyris: A synthetic biology company that engineered yeast strains to convert sugars into hydrocarbon fuels and high-value chemicals, including squalane and biofuels. Highly comparable to JBEI's microbial pathway engineering for fuels and bioproducts, although it has faced financial restructuring in recent years.
- Center for Advanced Bioenergy and Bioproducts Innovation (CABBI): A DOE Bioenergy Research Center led by the University of Illinois at Urbana-Champaign and the third sister BRC to JBEI. Directly comparable as a federally funded multi-institutional consortium pursuing bioenergy crops and microbial conversion pathways with similar scope and funding structure.
- LanzaTech: A private synthetic biology company that engineers microbes to convert carbon-rich gases (industrial flue gas, gasified biomass) into fuels and chemicals, including ethanol and sustainable aviation fuel precursors. Most directly comparable to JBEI's microbial-conversion-to-fuels work, but operating as a venture-backed commercial entity rather than a research institute.
Broad incumbents
- Novozymes: The world's largest industrial enzyme producer (now part of Novonesis), with significant penetration into biofuel and biorefining enzymes, including cellulases used in cellulosic ethanol. Broadly comparable to JBEI's enzymatic and microbial bioconversion work, but operating globally across food, agriculture, and household care as a much larger established incumbent.
- Ginkgo Bioworks: A platform synthetic biology company operating a 'bioworks' foundry for strain engineering and metabolic pathway development across industrial biotech, including biofuels, flavors, fragrances, and specialty chemicals. Broadly comparable to JBEI's engineered microbe platform but as a much larger commercial entity spanning many verticals beyond bioenergy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Joint BioEnergy Institute social profiles
Digital presenceJoint BioEnergy Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Joint BioEnergy Institute leadership team
Management profileNumber of profiles
Profiles4 records
Joint BioEnergy Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Joint BioEnergy Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Joint BioEnergy Institute
What does Joint BioEnergy Institute do?
JBEI conducts federally funded research to develop advanced biofuels and bioproducts from non-food lignocellulosic biomass, organized across four scientific divisions (Feedstocks, Deconstruction, Biofuels and Bioproducts, and Technology). Its deliverables include licensable intellectual property such as ionic liquid pretreatment processes, engineered microbial strains, and AI-driven strain engineering methods, which it transfers to industry through licensing and sponsored research agreements.
Is Joint BioEnergy Institute a public or private company?
Joint BioEnergy Institute is a private company. It is classified as state government owned and is currently operating.
When was Joint BioEnergy Institute founded?
Joint BioEnergy Institute was founded in 2007. It employs 51 to 100 people.
Where is Joint BioEnergy Institute based?
Joint BioEnergy Institute is headquartered in Emeryville, United States, in the North America region.
How does Joint BioEnergy Institute make money?
Three revenue lines are on record. U.S. Department of Energy Funding is the primary driver. The others are technology Licensing and IP and sponsored Research.
Who are Joint BioEnergy Institute's main competitors?
Direct peers on record are Codexis, ICM Inc., Gevo, Center for Bioenergy Innovation (CBI), Great Lakes Bioenergy Research Center (GLBRC), Amyris, Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) and LanzaTech. Broad incumbents are Novozymes and Ginkgo Bioworks.
Does Joint BioEnergy Institute have an API?
No public API is recorded for Joint BioEnergy Institute.
What industry is Joint BioEnergy Institute in?
Joint BioEnergy Institute's product category is Bioenergy Research. Its primary akta.pro industry code is IMAMALAA, Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates), with a secondary code of EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 541714 and its SIC code is 8731.